论文部分内容阅读
近日,国务院发布《关于进一步改革完善药品生产流通使用政策的若干意见》,从提高药品质量疗效,促进医药产业结构调整,整顿药品流通秩序,推进药品流通体制改革,规范医疗和用药行为,改革调整利益驱动机制等方面,明确了药品生产、流通、使用全链条的相关政策。作为药品领域的重磅新政,《若干意见》将对生产、流通、使用环节带来哪些重大影响?请看本期特别关注。
Recently, the State Council issued Several Opinions on Further Reforming and Perfecting the Policy on the Production and Circulation of Pharmaceutical Products, from improving the quality and efficacy of medicines, promoting the restructuring of the pharmaceutical industry, reorganizing the order of drug circulation, promoting the reform of the drug circulation system, standardizing the medical and drug use behaviors, and reforming and adjusting Interest-driven mechanism, etc., clear the drug production, circulation, the use of the whole chain of the relevant policies. As a heavy new policy in the field of pharmaceuticals, what are some of the major implications of the “Several Opinions” on production, distribution and use of products? Please read the special attention in this issue.